Related references
Note: Only part of the references are listed.Development of a peptide-based vaccine targeting TMPRSS2:ERG fusion-positive prostate cancer
Haydn Thomas Kissick et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Next-generation peptide vaccines for advanced cancer
Akira Yamada et al.
CANCER SCIENCE (2013)
TP53 genomics predict higher clinical and pathologic tumor response in operable early-stage breast cancer treated with docetaxel-capecitabine ± trastuzumab
Stefan Glueck et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma
Douglas J. Schwartzentruber et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
The Role of the Transcription Factor SIM2 in Prostate Cancer
Bin Lu et al.
PLOS ONE (2011)
Peptide binding predictions for HLA DR, DP and DQ molecules
Peng Wang et al.
BMC BIOINFORMATICS (2010)
WT1 peptide vaccinations induce CD4 and CD8 T cell immune responses in patients with mesothelioma and non-small cell lung cancer
Lee M. Krug et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts
Sergio A. Quezada et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Correction: Modeling Oncogenic Signaling in Colon Tumors by Multidirectional Analyses of Microarray Data Directed for Maximization of Analytical Reliability
Magdalena Skrzypczak et al.
PLoS One (2010)
FKBP51 Affects Cancer Cell Response to Chemotherapy by Negatively Regulating Akt
Huadong Pei et al.
CANCER CELL (2009)
Identification of the Transcription Factor Single-Minded Homologue 2 as a Potential Biomarker and Immunotherapy Target in Prostate Cancer
Mohamed S. Arredouani et al.
CLINICAL CANCER RESEARCH (2009)
Induction of p53-Specific Immunity by a p53 Synthetic Long Peptide Vaccine in Patients Treated for Metastatic Colorectal Cancer
Frank M. Speetjens et al.
CLINICAL CANCER RESEARCH (2009)
Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia.
Gemma G. Kenter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Induction of tumor-specific CD4+ and CD8+ T-Cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine
Marij J. P. Welters et al.
CLINICAL CANCER RESEARCH (2008)
Treatment of metastatic melanoma with autologous CD4+T cells against NY-ESO-1
Naomi N. Hunder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
A systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach
Peng Wang et al.
PLOS COMPUTATIONAL BIOLOGY (2008)
Immunotherapy of established (pre) malignant disease by synthetic long peptide vaccines
Cornelis J. M. Melief et al.
NATURE REVIEWS CANCER (2008)
CD8+ CTL priming by exact peptide epitopes in incomplete Freund's adjuvant induces a vanishing CTL response, whereas long peptides induce sustained CTL reactivity
Martijn S. Bijker et al.
JOURNAL OF IMMUNOLOGY (2007)
Multiple CD4 and CD8 T-cell activation parameters predict vaccine efficacy in vivo mediated by individual DC-activating agonists
Marij J. P. Welters et al.
VACCINE (2007)
Inhibition of breast cancer growth and invasion by single-minded 2s
Hyeong-Il Kwak et al.
CARCINOGENESIS (2007)
Increased expression of SIM2-s protein is a novel marker of aggressive prostate cancer
Ole Johan Halvorsen et al.
CLINICAL CANCER RESEARCH (2007)
Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain
LX Sun et al.
CANCER CELL (2006)
Cancer immunotherapy: moving beyond current vaccines
SA Rosenberg et al.
NATURE MEDICINE (2004)
Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy
YP Yu et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
MHCBN: a comprehensive database of MHC binding and non-binding peptides
M Bhasin et al.
BIOINFORMATICS (2003)
Peptide diffusion, protection, and degradation in nuclear and cytoplasmic compartments before antigen presentation by MHC class I
E Reits et al.
IMMUNITY (2003)
Established human papillomavirus type 16-expressing tumors are effectively eradicated following vaccination with long peptides
S Zwaveling et al.
JOURNAL OF IMMUNOLOGY (2002)
Importance of CD4+ T helper cell responses in tumor immunity
F Ossendorp et al.
IMMUNOLOGY LETTERS (2000)
Risks of leukaemia and solid tumours in individuals with Down's syndrome
H Hasle et al.
LANCET (2000)
Share Paper
